Skip to main content

Table 1 Descriptive clinical, laboratory and radiological data of studied cases (n = 50)

From: Effect of zinc supplementation on growth Hormone Insulin growth factor axis in short Egyptian children with zinc deficiency

  Mean ± SD Range
Age (years) 6.5 ± 3.05 3.20-10.90
Height SDS -3.12 ± 0.2 -2.15- -4.21
-GV after Zn (cm/3 months) 0.55 ± 0.1 0.1-2.23
-GV SDS after Zn +1.01 ± 0.2 -0.5 - +2.11
- Weight SDS -1.88 ± 0.62 -2.01- +0.55
- BMI SDS -1.77 ± 0.41 -2.10- -0.78
- Serum Zn (μg/dl) 56.76 ± 7.90 37.52-93.11
-Peak GH after insulin stimulation (ng/ml) 10.65 ± 2.01 7.61-13.20
-Peak GH after clonidine stimulation (ng/ml) 11.14 ± 1.41 6.92-14.11
- IGF-1 (ng/ml) 96.72 ± 11.5 36.52-115.69
-IGF-1 SDS -2.46 ± 0.11 -3.22- +0.55
- IGFBP-3 (ng/ml) 2436.12 ± 392 1195.45-3898.15
-BA (years) 3.7 ± 1.05 1.81-9.25
-BA SDS -1.75 ± 1.14 -2.44 - +0.22
  1. Results are expressed as mean ± SD and range, Zn: zinc, SDS: Standard deviation score, GV: Growth velocity, BMI: Body mass index, GH: Growth hormone, IGF-1: Insulin like growth factor-1, IGFBP-3: Insulin like growth factor binding protein-3, BA: bone age.